A Chart Review on the Feasibility and Safety of the Vincristine Irinotecan Pazopanib (VIPaz) Association in Children and Adolescents With Resistant or Relapsed Sarcomas

Background: Pediatric patients with relapsed or refractory sarcomas have poor outcome and need novel therapies that provide disease control while maintaining an acceptable quality of life. The safety of vincristine, irinotecan, and pazopanib (VIPaz) association has not yet been published in this pop...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Front Oncol
Autors principals: Russo, Ida, Di Paolo, Virginia, Crocoli, Alessandro, Mastronuzzi, Angela, Serra, Annalisa, Di Paolo, Pier Luigi, Di Giannatale, Angela, Miele, Evelina, Milano, Giuseppe Maria
Format: Artigo
Idioma:Inglês
Publicat: Frontiers Media S.A. 2020
Matèries:
Oncology
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7425124/
https://ncbi.nlm.nih.gov/pubmed/32850366
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2020.01228
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars